NeoVolta, Inc. 10-Q
Table
of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ Quarterly Report Under Section 13 or
15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended March 31, 2026
or
☐ Transition Report pursuant to Section 13 or
15(d) of the Securities Exchange Act of 1934
For the transition period from ________________
to ______________
Commission File Number:
001-41447
NeoVolta, Inc.
(Exact name of registrant as specified in its charter)
Nevada
82-5299263
(State or other jurisdiction of
incorporation)
(I.R.S. Employer Identification No.)
12195 Dearborn Place
Poway , CA
92064
(Address of principal executive offices)
(Zip code)
Registrant’s telephone number, including
area code: ( 800 ) 364-5464
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class
Trading Symbol (s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
NEOV
The NASDAQ Stock Market LLC
Warrants, each warrant exercisable for one share of common stock
NEOVW
The NASDAQ Stock Market LLC
Indicate by check mark whether the Registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes : ☒ No: ☐
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes :
☒ No: ☐
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.
See the definitions of “ large accelerated filer, ” “ accelerated filer, ” “ smaller reporting
company ” and “ emerging growth company ” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer ☒
Smaller reporting company ☒
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒
The number of shares outstanding of Common Stock,
par value $0.001 per share, as of May 14, 2026, was 42,711,301 shares
NEOVOLTA, INC.
FORM 10-Q
MARCH 31, 2026
INDEX
Page
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
3
PART I. FINANCIAL INFORMATION
4
Item 1. Financial Statements
4
Consolidated Balance Sheets as of March 31, 2026 and June 30, 2025 (Unaudited)
4
Consolidated Statements of Operations for the three months ended March 31, 2026 and 2025 (Unaudited)
5
Consolidated Statements of Operations for the nine months ended March 31, 2026 and 2025 (Unaudited)
6
Consolidated Statements of Stockholders’ Equity for the three and nine months ended March 31, 2026 and 2025 (Unaudited)
7
Consolidated Statements of Cash Flows for the nine months ended March 31, 2026 and 2025 (Unaudited)
8
Notes to Consolidated Financial Statements (Unaudited)
9
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
19
Item 3. Quantitative and Qualitative Disclosures About Market Risk
23
Item 4. Controls and Procedures
23
PART II. OTHER INFORMATION
24
Item 1. Legal Proceedings
24
Item 1A. Risk Factors
24
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
24
Item 3. Defaults Upon Senior Securities
24
Item 4. Mine Safety Disclosures
24
Item 5. Other Information
25
Item 6. Exhibits
26
Signatures
27
2
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on
Form 10-Q (this “Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform
Act of 1995. We make forward-looking statements under the “Risk Factors,” “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” and in other sections of this Report. In some cases, you can identify forward-looking
statements by the following words: “ anticipate, ” “ believe, ” “ continue, ” “ could, ”
“ estimate, ” “ expect, ” “ intend, ” “ may, ” “ ongoing, ”
“ plan, ” “ potential, ” “ predict, ” “ project, ” “ should, ”
or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the
statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity,
performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in
this Report.
You should read the matters
described in, and incorporated by reference in, “Risk Factors” and the other cautionary statements made in this Report, as
being applicable to all related forward-looking statements wherever they appear in this Report. We cannot assure you that the forward-looking
statements in this Report will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance on
forward-looking statements.
All forward-looking statements
speak only at the date of the filing of this Quarterly Report. You should not rely upon forward-looking statements as predictions of
future events. The reader should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions
and expectations reflected in or suggested by the forward-looking statements we make in this Quarterly Report are reasonable, we provide
no assurance that these plans, intentions or expectations will be achieved. We disclose important factors that could cause our actual
results to differ materially from our expectations under “Risk Factors” and “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report and our Annual Report on Form 10-K for
the year ended June 30, 2025, as filed with the SEC on September 29, 2025. These cautionary statements qualify all forward-looking statements
attributable to us or persons acting on our behalf. We do not undertake any obligation to update or revise publicly any forward-looking
statements except as required by law, including the securities laws of the United States and the rules and regulations of the SEC.
3
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
NEOVOLTA, INC.
Consolidated Balance Sheets
(Unaudited)
March 31,
June 30,
2026
2025
Assets
Current assets:
Cash and cash equivalents
$ 11,480,829
$ 794,836
Accounts receivable, net
6,131,115
2,983,841
Inventory, net
2,193,526
2,137,912
Prepaid expenses and other current assets (including prepaid inventory in amounts of $ 455,454 and $ 535,938 , respectively)
1,013,666
748,044
Note receivable, net (including accrued interest of $ 14,712 )
1,412,551
–
Total current assets
22,231,687
6,664,633
Construction in progress
1,079,015
–
Property and equipment, net
233,189
–
Net property and equipment
1,312,204
–
Intellectual property (net of accumulated amortization of $ 216,102 )
1,182,398
–
Other assets:
Lease right-of-use asset, net
836,471
140,540
Miscellaneous assets
101,562
–
Total assets
$ 25,664,322
$ 6,805,173
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
$ 727,886
$ 689,216
Accrued liabilities
1,303,494
78,934
Lease liability
103,805
140,540
Short-term notes payable
609,644
2,603,223
Total current liabilities
2,744,829
3,511,913
Payable to line of credit lender
–
383,538
Lease liability
738,163
–
Total liabilities
3,482,992
3,895,451
Commitments and contingencies (Note 5)
–
–
Stockholders' equity:
Common stock, $ 0.001 par value, 100,000,000 shares authorized, 42,711,301 shares and 34,124,873 shares issued and out- standing, respectively
42,711
34,125
Additional paid-in capital
57,726,276
28,652,731
Accumulated deficit
( 35,587,657 )
( 25,777,134 )
Total stockholders' equity
22,181,330
2,909,722
Total liabilities and stockholders' equity
$ 25,664,322
$ 6,805,173
See accompanying notes to unaudited financial statements
4
NEOVOLTA, INC.
Consolidated Statements of Operations
(Unaudited)
Three Months Ended
March 31,
2026
2025
Revenues from contracts with customers
$ 2,023,718
$ 2,014,105
Cost of goods sold
1,095,895
1,499,597
Gross profit
927,823
514,508
Operating expenses:
General and administrative
3,021,127
1,857,531
Research and development
403,887
27,947
Depreciation and amortization
128,458
–
Total operating expenses
3,553,472
1,885,478
Loss from operations
( 2,625,649 )
( 1,370,970 )
Other income (expense):
Loss on debt exchanges
( 408,028 )
–
Interest expense
( 51,810 )
( 78,499 )
Interest income
57,085
138
Total other income (expense)
( 402,753 )
( 78,361 )
Net loss
$ ( 3,028,402 )
$ ( 1,449,331 )
Weighted average shares outstanding - basic and diluted
40,189,804
33,490,603
Net loss per share - basic and diluted
$ ( 0.08 )
$ ( 0.04 )
See accompanying notes to unaudited financial statements.
5
NEOVOLTA, INC.
Consolidated Statements of Operations
(Unaudited)
Nine Months Ended
March 31,
2026
2025
Revenues from contracts with customers
$ 13,319,493
$ 3,675,922
Cost of goods sold
10,041,896
2,744,656
Gross profit
3,277,597
931,266
Operating expenses:
General and administrative
10,474,212
4,136,167
Research and development
519,594
78,888
Depreciation and amortization
240,290
–
Total operating expenses
11,234,096
4,215,055
Loss from operations
( 7,956,499 )
( 3,283,789 )
Other income (expense):
Loss on debt exchanges
( 1,266,030 )
–
Interest expense
( 645,644 )
( 103,045 )
Interest income
57,650
1,872
Total other income (expense)
( 1,854,024 )
( 101,173 )
Net loss
$ ( 9,810,523 )
$ ( 3,384,962 )
Weighted average shares outstanding - basic and diluted
36,436,915
33,412,117
Net loss per share - basic and diluted
$ ( 0.27 )
$ ( 0.10 )
See accompanying notes to unaudited financial statements.
6
NEOVOLTA, INC.
Consolidated Statement of Stockholders' Equity
Nine Months Ended March 31, 2026 and 2025
(Unaudited)
Additional
Total
Common Stock
Paid-in
Accumulated
Stockholders'
Shares
Amount
Capital
Deficit
Equity
Balance at June 30, 2025
34,124,873
$ 34,125
$ 28,652,731
$ ( 25,777,134 )
$ 2,909,722
Stock compensation expense
88,965
89
466,676
–
466,765
Net loss
–
–
–
( 1,243,322 )
( 1,243,322 )
Balance at September 30, 2025
34,213,838
34,214
29,119,407
( 27,020,456 )
2,133,165
Stock compensation expense
215,179
215
2,552,054
–
2,552,269
Issuance of common stock for asset acquisition
200,000
200
997,800
–
998,000
Issuance of common stock for debt exchanges
366,667
366
1,857,636
–
1,858,002
Issuance of common stock in private offering
1,200,000
1,200
2,998,800
–
3,000,000
Net loss
–
–
–
( 5,538,799 )
( 5,538,799 )
Balance at December 31, 2025
36,195,684
36,195
37,525,697
( 32,559,255 )
5,002,637
Stock compensation expense
133,378
133
( 206,404 )
–
( 206,271 )
Issuance of common stock in public offering
2,100,841
2,101
9,299,743
–
9,301,844
Issuance of common stock in private offering
4,000,000
4,000
9,996,000
–
10,000,000
Issuance of common stock for debt exchange
281,398
282
1,111,240
–
1,111,522
Net loss
–
–
–
( 3,028,402 )
( 3,028,402 )
Balance at March 31, 2026
$ 42,711,301
$ 42,711
$ 57,726,276
$ ( 35,587,657 )
$ 22,181,330
Additional
Total
Common Stock
Paid-in
Accumulated
Stockholders'
Shares
Amount
Capital
Deficit
Equity
Balance at June 30, 2024
33,236,091
$ 33,236
$ 25,304,732
$ ( 20,742,538 )
$ 4,595,430
Stock compensation expense
9,776
10
265,389
–
265,399
Net loss
–
–
–
( 964,494 )
( 964,494 )
Balance at September 30, 2024
33,245,867
33,246
25,570,121
( 21,707,032 )
3,896,335
Stock compensation expense
115,844
116
214,574
–
214,690
Exercise of common stock warrants
55,412
55
160,345
–
160,400
Net loss
–
–
–
( 971,137 )
( 971,137 )
Balance at December 31, 2024
33,417,123
33,417
25,945,040
( 22,678,169 )
3,300,288
Stock compensation expense
164,250
164
888,330
–
888,494
Issuance of common stock in private offering
543,500
544
1,086,456
–
1,087,000
Net loss
–
–
–
( 1,449,331 )
( 1,449,331 )
Balance at March 31, 2025
34,124,873
$ 34,125
$ 27,919,826
$ ( 24,127,500 )
$ 3,826,451
See accompanying notes to unaudited financial
statements.
7
NEOVOLTA, INC.
Consolidated Statements of Cash Flows
(Unaudited)
Nine Months Ended
March 31,
2026
2025
Cash flows used in operating activities:
Net loss
$ ( 9,810,523 )
$ ( 3,384,962 )
Adjustments to reconcile net loss to net cash used in operations:
Stock compensation expense
2,812,763
1,368,583
Loss on debt exchanges
1,266,030
–
Depreciation and other amortization expense
240,290
–
Amortization of right-of-use asset
110,236
–
Provision for expected credit losses/bad debt expense
591,765
238,441
Changes in assets and liabilities
Accounts receivable
( 3,636,878 )
( 788,929 )
Inventory
( 55,614 )
( 492,417 )
Prepaid expenses and other current assets
( 298,639 )
–
Other long term assets
( 101,562 )
( 462,717 )
Operating lease obligation
( 86,434 )
–
Accounts payable
( 411,712 )
3,660
Accrued expenses
1,223,425
16,826
Net cash flows used in operating activities
( 8,156,853 )
( 3,501,515 )
Cash flows used in investing activities:
Additions to Construction in Progress
( 627,498 )
–
Additions to Other Property & Equipment
( 657,877 )
–
Additions to Note Receivable
( 1,500,000 )
–
Net cash flows used in investing activities
( 2,785,375 )
–
Cash flows from financing activities:
Issuance of common stock in private offering
13,000,000
1,087,000
Issuance of common stock in public offering
9,301,844
–
Borrowings under line of credit
250,000
500,000
Repayments of line of credit
( 633,538 )
( 116,462 )
Borrowings under short-term notes payable
6,686,891
2,081,845
Repayments of short-term notes payable
( 6,976,976 )
( 661,729 )
Proceeds from exercise of common stock warrants
–
160,400
Net cash flows provided by financing activities
21,628,221
3,051,054
Net increase (decrease) in cash and cash equivalents
10,685,993
( 450,461 )
Cash and cash equivalents at beginning of period
794,836
986,427
Cash and cash equivalents at end of period
$ 11,480,829
$ 535,966
Supplemental disclosures of cash flow information
Cash paid for interest
$ 771,288
$ 22,845
Cash paid for income taxes
–
–
Cash paid for amounts included in operating lease liabilities
149,104
–
Supplemental disclosures of financing and investing activities
Issuance of common stock for debt exchanges
2,969,524
–
Addition of assets for common stock
998,000
–
Right-of-use assets obtained for operating lease liabilities
787,862
–
Purchases of construction in progress recorded in accounts payable
451,517
–
See accompanying notes to unaudited financial statements.
8
NEOVOLTA, INC.
Notes to Consolidated Financial Statements
(Unaudited)
( 1) Business
and Summary of Significant Accounting Policies
Description of Business
– NeoVolta Inc. (“we”, “our” or the "Company") is a Nevada corporation, which was formed on March
5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries
and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, initially
in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its
equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 4).
Interim Financial Information
– The Company has prepared the accompanying consolidated financial statements, without audit, in accordance with accounting
principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations
of the Securities and Exchange Commission (“SEC”). In the opinion of management, these consolidated financial statements contain
all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s consolidated financial
position as of March 31, 2026, the results of its operations for the three and nine month periods ended March 31, 2026 and 2025, the changes
in its stockholders’ equity for the three and nine month periods ended March 31, 2026 and 2025, and cash flows for the nine month
periods ended March 31, 2026 and 2025. The balance sheet as of June 30, 2025 has been derived from the Company’s June 30, 2025 financial
statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes
required for complete annual consolidated financial statements. The results of operations for the interim periods are not necessarily
indicative of the results to be expected for the full year. These consolidated financial statements should be read in conjunction with
our Annual Report on Form 10-K for the year ended June 30, 2025, as filed with the SEC on September 29, 2025.
Principles of Consolidation
- The consolidated financial statements include the accounts of the Company and its subsidiary, NeoVolta Power, LLC, which was formed
in January 2026 (see Note 2). The noncontrolling interests in this subsidiary, which are nonredeemable, will be accounted for as a separate
line within stockholders’ equity when recognized. All intercompany accounts and transactions have been eliminated in consolidation.
Acquisitions –
The Company evaluates acquisitions to first determine whether a set of assets acquired constitutes a business and should be accounted
for as a business combination. If the assets acquired are not a business, the transaction is accounted as an asset acquisition in accordance
with Accounting Standards Codification (“ASC”) 805-50, Asset Acquisitions (“ASC 805-50”), which requires
the acquiring entity to recognize assets acquired and liabilities assumed based on the cost to the acquiring entity on a relative fair
value basis, except for non-qualifying assets such as inventory.
Cash and Cash Equivalents
– The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to
be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured
limit of $250,000, per bank. At March 31, 2026, the Company maintained all of its parent and subsidiary company accounts at one bank and
the combined balances of all accounts exceeded the combined FDIC insurance limit by $ 11,230,829 .
Inventory
– Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s
main offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using
the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce
the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory
turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. The following table presents the components
of inventory as of March 31, 2026 and June 30, 2025:
Schedule of inventory
March 31,
June 30,
2026
2025
Raw materials, consisting of assembly parts, batteries and inverters
$ 815,229
$ 2,014,252
Finished goods
1,378,297
123,660
Total
$ 2,193,526
$ 2,137,912
9
Property and Equipment
– The Company capitalizes the cost of property and equipment and depreciates it over their estimated useful lives ranging from
1 to 7 years. No depreciation is recognized on construction in progress until the project is completed and placed in service.
Revenue Recognition
– The Company recognizes revenue in accordance with Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts
with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that
reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized
based on the following five step model:
· Identification of the contract with a customer
· Identification of the performance obligations in the contract
· Determination of the transaction price
· Allocation of the transaction price to the performance obligations in the contract
· Recognition of revenue when, or as, the Company satisfies a performance obligation
The Company generates revenues
from contracts with customers, consisting of a relatively small number of wholesale dealers and distributors, in California, Texas and
several other states. Two such customers represented approximately 71 % and 29 % of the Company’s revenues in the three months ended
March 31, 2026, however, no other dealers accounted for more than 10% of the revenues in such period. Those same two customers plus another
one represented approximately 39 %, 15 % and 11 % of the Company’s revenues in the nine months ended March 31, 2026. Those same three
customers also represented approximately 46 %, 25 % and 19 % of the Company’s accounts receivable as of March 31, 2026. Two such dealers
represented approximately 48 % and 15 % of the Company’s revenues in the three months ended March 31, 2025. Three such dealers represented
approximately 26 %, 24 % and 15 % of the Company’s revenues in the nine months ended March 31, 2025. Since all of the Company’s
revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the three and
nine months ended March 31, 2026 and 2025 is provided .
Allowance for Expected
Credit Losses – The Company recognizes an allowance for expected credit losses based on the assessed risk of loss for a
customer's account, reflecting the net amount expected to be collected. As of March 31, 2026 and June 30, 2025, our allowance for expected
credit losses for accounts receivable was $ 540,000 and $ 314,200 , respectively.
Amortization Expense
– Amortization expense applicable to intellectual property acquired in an acquisition of assets in October 2025 is recognized on
a straight-line basis over their estimated useful lives consisting of 2 years for software and information technology, 5 years for licensed
technology, and 10 years for owned technology.
Depreciation Expense
– Depreciation expense applicable to property and equipment which is placed in service is recognized on a straight-line basis over
their estimated useful lives ranging from 1 to 7 years.
Impairment Expense
– The Company accounts for impairment expense in accordance with the provisions of ASC 350-30, General Intangibles Other Than
Goodwill, for intellectual property and ASC 360-10-35, Property, Plant and Equipment – Subsequent Measurement, for other
property and equipment.
Long Term Leases –
The Company accounts for long term operating leases in excess of 12 months in accordance with the provisions of ASU 2016-02, Leases
(Topic 842) . Accordingly, the Company capitalizes the present value of the future lease obligations while recognizing an offsetting
lease liability and amortizes the related right-of-use asset each month over the term of the lease.
10
Loss Per Common Share
– Basic loss per common share is computed by dividing consolidated net loss available to common shareholders by the weighted-average
number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of
common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are
reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be
anti-dilutive. As of March 31, 2026, the Company had total outstanding common stock equivalents of 4,484,209 shares as follows: (i) 961,362
shares related to restricted stock units granted to officers and others since April 2024; (ii) 1,081,150 shares related to warrants issued
to investors in the public offering completed in August 2022; (iii) 2,391,697 shares for Non-Qualified Stock Options granted to employees
in August and December 2025 and to two executives in February 2026 in exchange for their surrendered RSUs; and (iv) 50,000 shares related
to restricted stock units granted to an officer in March 2022 (see Note 4).
Note Receivable –
Note receivable consists of a loan in the original principal amount of $ 1,500,000 to a private solar project development company. The
loan is in the form of a promissory note bearing interest at the rate of 6 % per annum with the principal and accrued interest being due
on demand on or after December 5, 2026.
Research and Development
Costs – Research and development costs are expensed as incurred.
Stock Compensation Expense
– Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award,
and is recognized as an expense over the requisite service period.
Fair
Value Measurement - Fair value is defined as the price that would be received for an asset or paid to
transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction
between market participants on the measurement date .
Assets and liabilities that are carried at fair
value are classified and disclosed in one of the following three categories:
Level 1 - Inputs
represent unadjusted quoted prices in active markets for identical assets or liabilities;
Level 2 - Inputs
include quoted prices for similar assets and liabilities in active markets that are either directly or indirectly observable; and
Level 3 - Inputs
are unobservable and considered significant to fair value measurement.
As more fully described in
Note 5, we have accounted for our acquisition of tangible and intangible assets from another company in October 2025 by allocating the
total purchase price paid at closing to the fair value of the assets acquired.
Use of Estimates –
Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles
generally accepted in the United States of America. Actual results could differ from those estimates.
Segment
Information – Management has determined that the Company operates in one
reportable segment, which is the development and commercialization of energy storage products. The Company's chief operating
decision maker (CODM) is its Chief Executive Officer, who reviews financial information presented on a company-wide basis. The CODM
primarily uses net loss, which is reported in the Statements of Operations, to assess financial performance and allocate resources.
These financial metrics are used by the CODM to make key operating decisions, such as the assessment of performance and allocation
of resources. The significant categories within net loss that the CODM regularly reviews are revenues, cost of goods sold, and
general and administrative expenses.
Recent Accounting Pronouncements
– From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”),
or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently
issued standards, including ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, and prospective
standards that are not yet effective, including ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense
Disaggregation disclosures (Topic 220-40): Disaggregation of Income Statement Expenses, are not expected to have a significant impact
on the Company’s consolidated financial statement disclosures upon adoption. The Company has considered all other recently issued
accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its consolidated financial
statements.
11
Liquidity – These consolidated financial statements have been prepared on a going
concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business.
The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary debt and equity
financing to continue operations and the attainment of profitable operations. With the proceeds of our three equity financings in the
nine months ended March 31, 2026 (see Note 4) and our existing financial resources, we believe we will have sufficient cash to operate
for at least the next 12 months.
(2)
Consolidated Subsidiary
In January 2026, we executed
a series of joint venture agreements with the U.S. affiliate of a foreign entity for the formation of a new domestic limited liability
company known as NeoVolta Power, LLC (“NVP”), a Delaware entity, to jointly own and operate a utility-scale battery manufacturing
facility in the State of Georgia. Pursuant to these agreements, as amended in April 2026, the Company has an 80% ownership interest in
the joint venture company, and the U.S. affiliate of the foreign entity has a 20% ownership interest (subject to service-based vesting
and forfeiture provisions), which will be accounted for as a noncontrolling interest based on the estimated fair value of its services
as contributed to the joint venture (none as of March 31, 2026).
Under the terms of the joint
venture agreements, we made our initial capital contribution of $ 7,000,000 of cash to NVP in January 2026, in order to fund the startup
of construction on the battery manufacturing facility. The minority partner is not required to make cash contributions and will instead
contribute ongoing operational and technical services to the joint venture based on its project development and supply chain expertise.
As of March 31, 2026, approximately $ 1,208,000 of the initial cash capital contribution had been spent as capital expenditure on the manufacturing
facility and is reflected on our consolidated balance sheet, mostly as Construction in progress. As of March 31, 2026, approximately $ 284,000
had been spent on operating expenses for the joint venture and is included in our consolidated statement of operations in General and
administrative expenses.
In
accordance with the joint venture agreements, we expect to make an additional cash capital contribution of $ 8,000,000 to NVP in June 2026
primarily to fund the purchase of equipment for the battery manufacturing facility. The plant will be constructed in phases with the initial
phase expected to be completed in the summer of 2026 leading to the commencement of limited production of batteries for sale to customers.
Further, we are expected to make additional capital contributions to NVP through June 30, 2027 in total amounts of up to $ 25,000,000 ,
pursuant to the joint venture agreements, to fund equipment purchases, working capital requirements and other items as may be needed by
NVP. We presently anticipate funding our additional capital contributions from the proceeds of one or more one equity and/or debt financings,
subject to market conditions. However, there can be no assurance that we will be successful in raising sufficient proceeds from any public
or private offerings in order to fully satisfy our obligations for the additional capital contributions to NVP. To the extent that we
may be unable to raise sufficient proceeds in order to fully satisfy our obligations for the additional capital contributions to NVP,
the parent company of the same foreign entity will be permitted to bring in one or more new members to fund such additional capital contributions
which would dilute our 80% majority ownership of NVP.
(3) Debt
In September 2024, we entered
into an agreement with a newly formed financing entity whereby we obtained a line of credit for borrowings of up to $5,000,000. Under
this agreement, we agreed to make periodic payments to the lender of accrued interest, at the rate of 16% per annum, on any outstanding
borrowings that we make, with the principal and any unpaid accrued interest being due at maturity in September 2028. In February 2026,
we made full payment to the lender of our outstanding borrowings of $ 633,538 , plus accrued interest of $ 100,779 , and the line of credit
borrowing arrangement was terminated.
In November 2024, we initiated
short-term borrowings from a commercial accounts receivable lender, under a loan agreement allowing for borrowings secured by certain
property interests of up to a principal amount of $4,000,000. In the nine months ended March 31, 2026, we made borrowings from this lender
to finance customer shipments and related costs in the total amount of $ 6,686,891 . The lender charges a placement fee of 1% on each borrowing
and assesses interest at the rate of 2.5% per month on the outstanding borrowings. Borrowings are to be repaid upon the earlier of: (i)
120 days from the borrowing date; or (ii) receipt of payment from the customer. In the event of default, interest is assessed at the default
rate of 1% per 7 days. In the nine months ended March 31, 2026, we repaid $ 6,976,976 of such borrowings, including accrued interest and
fees, and made three conversions of loan principal and accrued interest totaling $ 1,703,494 into equity (see Note 4), leaving an outstanding
balance as of that date, including accrued interest and fees, of $ 609,644 (see Note 7) . Based
on the fair value of our common stock at the time of the three conversions, we recognized non-operating losses on the debt exchanges during
the nine months ended March 31, 2026 in the total amount of $ 1,266,030 .
12
(4) Equity
Common Stock –
In November 2025, the Company entered into subscription agreements for a private equity offering with an accredited investor group under
which the Company issued a total of 1,200,000 shares of its common stock to the investor group in December 2025 at an offering price of
$2.50 per share, resulting in gross proceeds to the Company in the amount of $ 3,000,000 . The Company is using the proceeds of this private
offering to meet working capital needs and for other general corporate purposes.
In January 2026, we closed
a securities purchase agreement with a group of institutional investors, pursuant to which the Company sold to the purchasers, in a registered
direct offering, a total of 2,100,841 shares of our common stock at an offering price of $4.76 per share. The gross proceeds to the Company
from the registered direct offering were $ 10,000,000 and the net proceeds were $ 9,301,844 , after deducting offering expenses payable by
the Company. We are using the net proceeds from this offering for working capital and general corporate purposes.
In February 2026, we closed
another private equity offering in conjunction with our formation of a new joint venture company. In that offering we sold a total of
4,000,000 shares of our common stock at an offering price of $2.50 per share to the U.S. investment arm of our joint venture partner,
resulting in gross proceeds to the Company in the amount of $ 10,000,000 . We have invested $ 7,000,000 of those proceeds in the joint venture
company in order to satisfy our initial capital contribution, as required under the joint venture agreements, and are using the remaining
proceeds from this offering for working capital and general corporate purposes (see Note 2).
In the nine months ended March
31, 2026, the Company entered into three voluntary exchange agreements with the commercial lender providing short-term financing for customer
shipments and related costs whereby we issued a total of 648,065 shares of our common stock having a fair value of $ 2,969,524 to the lender
in exchange for total reductions in our outstanding principal loan balance amounting to $ 1,703,494 . The Company recognized non-operating
losses on these three exchanges in the total amount of $ 1,266,030 (see Note 3).
In August 2022, the Company
completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common
stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock
at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at
closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date
of issuance and will expire five years from the date of issuance.
In the underwritten public
offering, a total of 1,121,250 Units, including exercise of the underwriter’s overallotment option, were sold at an offering price
to the public of $4.00 per Unit. The gross proceeds of the offering were $ 4,485,000 and the net proceeds, after deduction of underwriting
discounts and other offering costs were approximately $ 3,780,000 . The Company also granted the underwriter non-tradeable warrants to purchase
a total of 58,500 shares of common stock at an exercise price of $ 4.40 per share for a period of five years.
Warrants – As
of March 31, 2026, there were outstanding Warrants for a total of 1,081,150
shares of common stock issued to investors which are exercisable at any time up to August
1, 2027 . The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the
terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current
prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain
the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants,
the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the
Warrants, until such time as there is an effective registration statement and current prospectus. The following table presents activity
with respect to the Company’s warrants for the nine months ended March 31, 2026:
Schedule of warrant activity
Number
Wtd. Avg.
Wtd. Avg.
Aggregate
of
Exercise
Remaining
Intrinsic
Shares
Price
Term (Yrs.)
Value
Outstanding at June 30, 2025
1,081,150
$ 4.00
2.1
Warrants issued
–
–
–
Warrants exercised/forfeited
–
–
–
Outstanding at March 31, 2026
1,081,150
$ 4.00
1.3
$ –
Exercisable at March 31, 2026
1,081,150
$ 4.00
1.3
$ –
13
These warrants were issued
in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.
Stock Compensation Expense
– As of March 31, 2026, we have issued Non-Qualified Stock Options to a group of our non-executive employees to purchase a total
of 159,000 shares of common stock, net of forfeitures, at the then-current stock price of $ 3.04 - 3.60 per share, pursuant to the provisions
of our 2019 Stock Option Plan. These options are exercisable for a period of 5 years from the date of issuance and will become vested
on a ratable basis over a period of 3 years from the date of issuance. Using the Black-Scholes valuation model, and assuming expected
volatility of 78.6 - 81.5 % and current interest rate of 4.1 - 4.3 %, we calculated that the total fair value of these options at issuance was
approximately $ 366,000 and are amortizing this total amount to stock compensation expense on a straight-line basis over the 3 -year vesting
period of the options.
On February 23, 2026, we issued
Non-Qualified Stock Options to two executive employees to purchase a total of 2,232,697 shares of common stock at the current stock price
of $3.54 per share, in exchange for surrender of their right to receive a total of 1,520,000 shares of restricted common stock. Using
the Black-Scholes valuation model, and assuming expected volatility of 81.5 % and current interest rate of 4.1 %, we calculated that the
total fair value of these options at issuance was approximately $ 5,380,800 , (see further disclosure below).
The following table presents
activity with respect to our Non-Qualified Stock Options for the nine months ended March 31, 2026:
Schedule of non qualified stock options
Number
Wtd. Avg.
Wtd. Avg.
Aggregate
of
Exercise
Remaining
Intrinsic
Shares
Price
Term (Yrs.)
Value
Outstanding at June 30, 2025
–
$ –
Options issued
2,397,697
3.54
Options exercised/forfeited
( 6,000 )
3.60
Outstanding at March 31, 2026
2,391,697
$ 3.54
4.9
$ –
Exercisable at March 31, 2026
–
$ 3.54
4.9
$ –
In April 2024, we
entered into an employment agreement with a new Chief Executive Officer (“CEO”), providing for an initial term extending
through June 30, 2027, which will be automatically renewed for additional one-year terms unless either party chooses not to renew
it. Pursuant to the agreement, our new CEO received an initial equity grant equal to 1,280,000 restricted stock units
(“RSUs”). As approved by the Compensation Committee of the Company’s Board of Directors, our CEO surrendered all
of these RSUs and earned performance grants of approximately $ 1.0 million on February 23, 2026, in exchange for newly-issued options
to purchase a total of 1,880,166
shares of common stock, at the current stock price of $3.54 per share, which will vest at the rate of 25% per year for 4 years,
subject to his continued service to the Company on each vesting date. Such number of options was calculated using a methodology
intended to replicate the equivalent value of the cancelled RSUs and the remaining unrecognized compensation cost of RSUs of
approximately $1.5 million is to be expensed on a straight-line basis over the 4-year vesting period of the options.
In February 2025, we entered
into an amended and restated employment agreement with our Chief Financial Officer (“CFO”). The initial term of the employment
agreement ends on December 31, 2027 and will be automatically renewable for additional one-year terms unless either party chooses not
to renew the agreement. Pursuant to the agreement, we issued our CFO an award of 240,000 RSUs. As approved by the Compensation Committee
of the Company’s Board of Directors, our CFO surrendered all of these RSUs on February 23, 2026, in exchange for newly-issued options
to purchase a total of 352,531 shares of common stock, at the current stock price of $3.54 per share, which will vest at the rate of 25%
per year for 4 years, subject to his continued service to the Company on each vesting date. Such number of options was calculated using
a methodology intended to replicate the equivalent value of the cancelled RSUs and the remaining unrecognized compensation cost of RSUs
of approximately $0.6 million are expensed on a straight-line basis over the 4-year vesting period of the options.
14
In January 2025, we entered
into an employment agreement with our former Chief Operating Officer (“COO”) and former Chief Business Officer (“CBO”),
which individual resigned from the Company on January 31, 2026 and received a lump-sum severance payment of $ 50,000 . Pursuant to the agreement,
we issued an award of 150,000 RSUs vesting in three annual installments, of which 50,000 RSUs had been vested at the time of his resignation
and the remaining 100,000 RSUs were surrendered. In October 2025, we entered into employment agreements with our new COO and our new Chief
Technology Officer. Pursuant to their employment agreements, we granted each of the two new officers an award of 450,000 RSUs ( 900,000
RSUs in total), vesting in three annual installments (see Note 4). For all of these awards, we have calculated the grant date value of
such awards and are amortizing it as stock compensation expense over the underlying vesting periods. We have recognized stock compensation
expense applicable to all RSU awards in the nine months ended March 31, 2026 and 2025 in the amounts of $ 1,543,272 and $ 693,622 , respectively.
In February 2025, we entered
into a referral agreement with a marketing company to sell our products to qualified solar and energy storage system installers through
December 31, 2026. Pursuant to the agreement, the only compensation that the marketing company will be entitled to receive is the issuance
of shares of our common stock in exchange for reaching specified target levels of product sales, up to a maximum total of 2,000,000 shares
for reaching a total of 2,500 units sold and paid for. In accordance with ASC 718, we are accounting for this agreement based on our periodic
assessments of the probability of reaching such target levels.
In conjunction with our public
offering in August 2022, we appointed three new independent directors and adopted a new compensation plan for all independent directors
based on an annual compensation amount of $65,000 with not less than 70% of such amount paid in shares of our common stock, calculated
based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined
by each director. As of March 31, 2026 and 2025, we recorded an accrual of $ 146,250 of compensation expense (of which $131,625 will be
settled through the issuance of shares) for our three independent directors under this plan.
In the nine months ended March
31, 2026, we recognized total non-cash stock compensation expense of $ 2,812,763 as follows: (i) $ 1,543,272 for the amortized value of
the RSUs granted to our executive officers and key employees; (ii) $ 131,625 for the amortized value of the portion of the compensation
plan for our independent directors that is attributable to stock; (iii) $ 259,724 for the value of the shares issuable to a distribution
company pursuant to an April 2025 distribution agreement; (iv) $ 673,668 for the value of the shares issuable to various consultants; and
(v) $ 204,475 for the amortized value of the Non-Qualified Stock Options issued to non-executive employees in August 2025 and to two executives
in February 2026 in exchange for their surrendered RSUs. There was a total of 437,522 shares of our common stock that were issued to various
grantees for services in the nine months ended March 31, 2026, of which 184,700 shares were previously expensed in the year ended June
30, 2025.
In the nine months ended March
31, 2025, we recognized total non-cash stock compensation expense of $ 1,368,583 as follows: (i) $ 693,622 for the amortized value of the
RSUs granted to our three officers and two other individuals; (ii) $ 131,625 for the amortized value of the portion of the compensation
plan for our independent directors that is attributable to stock; (iii) $ 438,000 for the March 2025 issuance of 150,000 shares of our
common stock to a consultant for his advisory services in the area of energy regulatory matters; (iv) $ 62,158 for the amortized value
of the shares potentially issuable to a marketing company pursuant to a February 2025 referral agreement; and (v) $ 43,178 for the March
2025 issuance of 14,250 shares of our common stock to a consultant for marketing services. There was a total of 289,870 shares of our
common stock that were issued to various grantees for services in the nine months ended March 31, 2025, of which 125,620 shares were previously
expensed in the year ended June 30, 2024.
Other Matters –
In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with
an authorization for the issuance of up to 2,500,000 shares of common stock. In December 2024, the Plan was amended to increase the number
of shares of common stock authorized for issuance by 5,000,000 shares. The Plan is designed to provide for future discretionary grants
of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of March
31, 2026, we have made total awards of 4,403,746 shares under the Plan as follows: (i) RSUs for 1,536,362 shares granted to our executive
officers and key employees, as noted above; (ii) 209,943 shares for the services of our three independent directors in the years ended
June 30, 2025, 2024 and 2023, pursuant to the compensation plan adopted in August 2022 for independent directors; (iii) 265,744 shares
granted to various consultants for their contracted services; and (iv) 2,391,697 shares for Non-Qualified Stock Options to purchase common
stock granted to employees beginning in August 2025 and to two executives in February 2026 in exchange for surrendered RSUs. As of March
31, 2026, there were a total of 3,096,254 shares available for future issuance under the Plan.
15
Preferred Stock –
The Company is authorized to issue up to 5,000,000 shares of preferred stock. Our articles of incorporation authorize the board to issue
these shares in one or more series, to determine the designations and the powers, preferences and relative, participating, optional or
other special rights and the qualifications, limitations and restrictions thereof. No such preferred stock has been issued to date.
(5) Asset
Purchase Agreement
In October 2025, we closed
an Asset Purchase Agreement with Neubau Energy Inc. (“Neubau”), a privately-owned company
based in California, and its shareholders, whereby the Company acquired substantially all of Neubau’s assets consisting mostly
of intellectual property and other intangible assets along with a smaller amount of tangible fixed assets. Neubau has developed
a proprietary battery storage module but has not had any commercial sales of the product. With this acquisition, the Company is able to
produce and sell Neubau’s proprietary module, which is complementary to the Company’s products. Sales of the proprietary battery
storage module by the Company are expected to begin in calendar year 2026.
The total consideration paid
at closing was approximately $ 1.5 million consisting of cash in the amount of $ 500,000 and 200,000 shares of the Company’s common
stock with a fair market value of $ 998,000 . The Company will also pay Neubau a royalty of $ 10.00
per unit of Neubau’s proprietary module sold by the Company for a period of three years
following the closing, to be accounted for as a period expense as there is currently no reliable estimate of the future sales of this
new product. Additionally, Neubau has the right to receive contingent consideration of up to 4,000,000 additional shares of the
Company’s common stock if certain sales milestones related to Neubau’s proprietary product are met within specified time periods
through December 31, 2028 , to be accounted for as a period expense as there is currently no reliable
estimate of the future sales of this new product .
The Company is accounting
for this transaction as an acquisition of assets and has assigned the total purchase price paid at closing, taking into account the probability
assessment of the contingent consideration noted above, to the fair value of the assets acquired, as summarized in the table below. For
the tangible property and equipment acquired, we began recognizing depreciation expense from the acquisition date and have recorded depreciation
expense in the amount of $ 16,746 as of March 31, 2026.
For the intellectual property acquired, we began recognizing amortization expense from the acquisition date and have recorded amortization
expense in the amount of $ 216,102
as of March 31, 2026. Shown below is a summary by Balance Sheet classification of the allocated fair values that we assigned to the acquired
assets as of the acquisition date based upon an independent valuation performed by a professional valuation consulting firm:
Schedule of acquired assets
Property and equipment
Tooling and manufacturing equipment
$ 99,500
Intellectual property
Owned technology
522,490
Licensed technology
59,780
Software and information technology
816,230
$ 1,498,000
In conjunction with closing
the asset purchase, we entered into employment agreements with the two principals of Neubau covering a three-year period ending September
30, 2028. One of the principals was appointed as the Company’s Chief Operating Officer replacing our former Chief Operating Officer
engaged in January 2025, who has since resigned, in that capacity. Pursuant to their employment agreements, we granted each of the two
new officers an award of 450,000 RSUs ( 900,000 RSUs in total), vesting in three annual installments (see Note 4).
16
(6) Commitments
and Contingencies
Effective February 1, 2025,
the Company relocated its corporate and manufacturing office space to a nearby facility in Poway, California, under a 13-month sublease
agreement with the sublandlord, at a base rental of $ 18,638 per month. We are accounting for the lease agreement as an operating lease
under ASU 2016-02, Leases (Topic 842) . Accordingly, the Company has capitalized the present value of the future lease obligations
and is amortizing the related right-of-use asset each month over the term of the lease. Effective October 1, 2025, we entered into an
extension of our sublease agreement with the sublandlord whereby we extended the term of the sublease agreement for an additional five
years and one month from the original expiration date of February 28, 2026 to the extended expiration date of March 31, 2031. As a result
of the extension, which was accounted for as a modification, we remeasured the lease liability using the discount rate as of October 1,
2025, and recorded increases to the Company’s operating lease liability and right-of-use asset of $ 787,862 during the nine months
ended March 31, 2026. The rate implicit in the extended sublease agreement was not readily determinable and, therefore, we used the Company’s
incremental borrowing rate of 13.75 % based on the Company’s borrowing capability over a similar term of the extended sublease agreement
utilizing the effects of full collateralization.
Future undiscounted lease
payments under the extended lease agreement are approximately $ 1.2
million, exclusive of operating expenses and obligations under the existing lease agreement. Future operating lease minimum payments,
together with their present value as of March 31, 2026, are summarized as follows:
Schedule of future operating lease minimum payments
Year ending June 30, 2026
$ 54,915
Year ending June 30, 2027
223,322
Year ending June 30, 2028
232,255
Year ending June 30, 2029
241,545
Year ending June 30, 2030
251,207
Thereafter
172,172
Total future minimum lease payments
1,175,416
Less amounts representing interest
( 333,448 )
Present value of lease liability
841,968
Current portion of operating lease liability
( 103,805 )
Long-term portion of operating lease liability
$ 738,163
We are dependent on our two
main component vendors for our supplies of batteries, inverters and other raw materials and the inability of these single-source suppliers
to deliver necessary components of our products according to our schedule and at prices, quality levels and volumes acceptable to us,
or our inability to efficiently manage these components, could have a material adverse effect on our consolidated financial condition
and operating results. Beginning in April 2025, the Trump Administration implemented a significant increase in tariff rates based on the
authority of the International Emergency Economic Powers Act (“IEEPA”) on all goods imported from China, although it was temporarily
suspended for 90 days in April 2025 and the tariff rate was lowered in November 2025, subject to judicial review. In February 2026, the
Supreme Court declared the tariffs to be unconstitutional based on the authority of IEEPA, therefore, the Administration is considering
alternative approaches to implementing tariffs that it believes would be sustained in a judicial review. Prior to the tariff escalation
in April 2025, we had anticipated the likelihood of facing such a tariff increase and began stockpiling our inventory of these two components
in order to reduce the impact of the tariffs.
In conjunction with the closing
of our Asset Purchase Agreement with Neubau Energy Inc. in October 2025, we granted the sellers
the right to receive contingent consideration of up to 4,000,000 additional shares of our common stock if certain sales milestones
related to Neubau’s proprietary battery storage product are met within specified time periods through December 31, 2028 (see Note
5).
17
From time to time in the ordinary
course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is
not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether
meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in
diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal
matters for which losses are not probable and estimable.
(7) Subsequent
Events
On
April 8, 2026, we entered into a one-year revolving credit agreement with our depository bank providing for borrowings of up to $3,000,000
at an annual interest rate of 2% above the applicable secured overnight financing rate (“SOFR”), plus an adjustment
of up to 0.1 % per annum. The proceeds of any borrowings made under this credit
agreement are to be used for working capital purposes. In conjunction with the credit agreement,
we were required to transfer $3,150,000 of cash into a restricted account at our depository bank as collateral. We made an initial draw
under the credit agreement to fully repay our outstanding borrowings from a commercial accounts receivable lender in
late April 2026 in the amount of approximately $620,000 (see Note 3). As of the date of this report, our outstanding borrowings under
this credit agreement remain at $620,000.
On
April 20, 2026, we entered into a Management Services Agreement with an affiliate of the foreign entity referenced in our formation
of a joint venture in Note 2, pursuant to which that affiliate agreed to provide sales and marketing
coordination services to us in connection with our commercial and industrial battery energy storage business. As consideration for the
services, we agreed to issue the affiliate 1,200,000 shares of our common stock which vests in four equal semi-annual installments of
300,000 shares each on the 6-month, 12-month, 18-month, and 24-month anniversaries of the effective date.
18
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Introduction
This information should be
read in conjunction with the interim unaudited consolidated financial statements and the notes thereto included in this Quarterly Report
on Form 10-Q, and the audited financial statements and notes thereto and "Item 7. Management’s Discussion and Analysis of Financial
Condition and Results of Operations”, contained in our Annual Report on Form 10-K for the year ended June 30, 2025, filed with the
Securities and Exchange Commission on September 29, 2025 (the “Annual Report”).
Certain capitalized terms
used below and otherwise defined below, have the meanings given to such terms in the footnotes to our unaudited consolidated financial
statements included above under “Part I - Financial Information” - “Item 1. Financial Statements”.
Unless the context requires
otherwise, references to the “Company , ” “we , ” “us,” “our , ” “NEOV”,
refer specifically to NeoVolta, Inc.
In addition, unless the context
otherwise requires and for the purposes of this Report only:
· “Exchange Act” refers to the Securities Exchange Act of 1934, as amended;
· “SEC” or the “Commission” refers to the United States Securities and Exchange Commission; and
· “Securities Act” refers to the Securities Act of 1933, as amended.
Overview
We are a designer, manufacturer,
and seller of high-end Energy Storage Systems (or ESS), primarily our NeoVolta NV14, NV14-K, and NV-24, which can store and use energy
via batteries and an inverter at residential or commercial sites. We were founded to identify new ways to leverage emerging technologies
with the dynamic changes that are taking place in the energy delivery space. We primarily market and sell our products directly to our
certified solar installers and solar equipment distributors. We are also pursuing agreements with residential developers, commercial developers,
and other commercial opportunities. Because we are purely dedicated to energy storage systems, virtually all our current resources and
efforts go into further developing our flagship NV14, NV14-K, and NV-24 products, while focusing on specific industry needs for our next
generation of products. We believe we are unique in the marketplace due to our low cost, our innovative battery chemistry, our product
versatility and our commitment to installer service. Because of these factors, we believe NeoVolta is uniquely equipped to establish itself
as a major player in the energy storage market.
As further discussed below
under “Liquidity and Capital Resources,” we completed an underwritten public offering of our equity securities in the form
of Units in August 2022. We sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The
gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs,
were approximately $3,780,000. We have used the proceeds of this public offering to increase our current production capacity, expand our
product portfolio, enlarge our product marketing and sales efforts, and for other general corporate purposes.
In January 2026, we formed
a joint venture with the U.S. affiliate of a foreign entity to jointly own and operate a new utility-scale battery manufacturing facility
in the State of Georgia. We have an 80% ownership interest in the joint venture company, with the U.S. affiliate of the foreign entity
having a 20% ownership interest (subject to service-based vesting and forfeiture provisions). In accordance with the joint venture agreements,
as amended in April 2026, we made our initial capital contribution to the joint venture of $7,000,000 in January 2026 and expect to make
an additional capital contribution of $8,000,000 in June 2026 as well as additional capital contributions of up to $25,000,000 through
June 30, 2027, which will require us to secure significant future infusions of equity and/or debt financing. The plant will be constructed
in phases with the initial phase expected to be completed in the summer of 2026 leading to the commencement of limited production of batteries
for sale to customers.
19
Upon completion, this new
facility is anticipated to provide the capacity for us to greatly expand our line of new energy storage products as an integrated energy
solutions leader and generate substantial amounts of both customer revenues and net operating cash flows over an extended period of time.
Results of Operations
The following discussion
reflects the Company’s revenues and expenses for the three and nine month periods ended March 31, 2026 and 2025, as reported in
our consolidated financial statements included in Item 1.
Comparison of three months ended March 31,
2026 versus three months ended March 31, 2025
Revenues - Revenues
from contracts with customers for the three months ended March 31, 2026 were $2,023,718 compared to $2,014,105 for the three months ended
March 31, 2025. Such static level of revenues was primarily due to expiration of the federal solar tax credit for individuals and various
other macroeconomic factors arising in the current quarter impacting not only the domestic solar industry but the overall economy in general.
Cost of Goods Sold
- Cost of goods sold for the three months ended March 31, 2026 were $1,095,895 compared to $1,499,597 for the three months ended March
31, 2025. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage
systems that were sold in each fiscal period and resulted in gross profits on such sales of approximately 46% and 26%, respectively, with
the increase being largely due to an upward out of period adjustment reflected in the current quarter related to higher inventory cost
recognition in the immediately preceding quarter.
General and Administrative
Expense - General and administrative expenses for the three months ended March 31, 2026 were $3,021,127 compared to $1,857,531 for
the three months ended March 31, 2025. Such increase was mainly due to our continuing rapid expansion of both our marketing and other
product development expenses since the engagement of a new chief executive officer in April 2024, including the hiring of a significant
number of new employees. The addition of these personnel has resulted in a higher level of both cash compensation expense and other associated
expenses, such as promotion and travel, as well as non-cash stock compensation expenses related to the Company’s equity incentive
programs.
Research and Development
Expense - Research and development expenses for the three months ended March 31, 2026 were $403,887 compared to $27,947 for the three
months ended March 31, 2025. Such fluctuation was largely due to the recent acceleration of our product development efforts.
Depreciation and Amortization
Expense - Depreciation and amortization expenses for the three months ended March 31, 2026 were $128,458 compared to zero for the
three months ended March 31, 2025. Such fluctuation was primarily attributable to our closing of an acquisition of intangible and tangible
assets from Neubau Energy Inc., which closed in October 2025.
Other Income and Expense
– Loss on debt exchanges for the three months ended March 31, 2026 was $408,028 compared to zero for the three months ended March
31, 2025, and resulted from an exchange agreement entered into with one of our lenders in January 2026. Interest expense for the three
months ended March 31, 2026 was $51,810 compared to $78,499 for the three months ended March 31, 2025, reflecting interest attributable
to a lower level of borrowings made under our lender credit arrangements obtained since September 30, 2024. Interest income for the three
months ended March 31, 2026 was $57,085 compared to $138 for the three months ended March 31, 2025, due to a higher average level of investable
cash in the three months ended March 31, 2026.
Net Loss - Net loss
for the three months ended March 31, 2026 was $3,028,402 compared to $1,449,331 for the three months ended March 31, 2025, representing
the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for
these net losses due to the uncertainty of its ultimate realization.
20
Comparison of nine months ended March 31, 2026
versus nine months ended March 31, 2025
Revenues - Revenues
from contracts with customers for the nine months ended March 31, 2026 were $13,319,493 compared to $3,675,922 for the nine months ended
March 31, 2025. Such increase in our revenues was primarily due to the rapid expansion of various
new sales channels outside of our traditional focus on the local installer market in the Southern California area while maintaining essentially
the same price points since the engagement of our new chief executive officer in April 2024 .
Cost of Goods Sold
- Cost of goods sold for the nine months ended March 31, 2026 were $10,041,896 compared to $2,744,656 for the nine months ended March
31, 2025. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage
systems that were sold in each fiscal year and resulted in gross profits on such sales of approximately 25% in each period, in accordance
with our customary expectations.
General and Administrative
Expense - General and administrative expenses for the nine months ended March 31, 2026 were $10,474,212 compared to $4,136,167 for
the nine months ended March 31, 2025. Such increase was mainly due to our continuing rapid expansion of both our marketing and other product
development expenses since the engagement of a new chief executive officer in April 2024, including the hiring of a significant number
of new employees. The addition of these personnel has resulted in a higher level of both cash compensation expense and other associated
expenses, such as promotion and travel, as well as non-cash stock compensation expenses related to the Company’s equity incentive
programs.
Research and Development
Expense - Research and development expenses for the nine months ended March 31, 2026 were $519,594 compared to $78,888 for the nine
months ended March 31, 2025. Such fluctuation was largely due to the recent acceleration of our product development efforts.
Depreciation and Amortization
Expense - Depreciation and amortization expenses for the nine months ended March 31, 2026 were $240,290 compared to zero for the nine
months ended March 31, 2025. Such fluctuation was primarily attributable to our closing of an acquisition of intangible and tangible assets
from Neubau Energy Inc., which closed in October 2025.
Other Income and Expense
– Loss on debt exchanges for the nine months ended March 31, 2026 was $1,266,030 compared to zero for the nine months ended March
31, 2025, and resulted from three exchange agreements entered into with one of our lenders since October 2025. Interest expense for the
nine months ended March 31, 2026 was $645,644 compared to $103,045 for the nine months ended March 31, 2025, reflecting interest attributable
to a higher level of borrowings made under our lender credit arrangements obtained since September 30, 2024. Interest income for the nine
months ended March 31, 2026 was $57,650 compared to $1,872 for the nine months ended March 31, 2025, due to a higher average level of
investable cash in the nine months ended March 31, 2026.
Net Loss - Net loss
for the nine months ended March 31, 2026 was $9,810,523 compared to $3,384,962 for the nine months ended March 31, 2025, representing
the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for
these net losses due to the uncertainty of its ultimate realization.
Liquidity and Capital Resources
Operating activities.
Net cash used in operating activities in the nine months ended March 31, 2026 was $8,156,853 compared to $3,501,515 in the nine months
ended March 31, 2025. This increase was largely due to the current period increase in our comparative net loss, primarily resulting from
an increase in our previously noted cash operating expenses for personnel and related costs, as well as the relatively higher changes
in our net working capital needs, including a recent increase in our outstanding accounts receivable.
Investing activities.
Net cash used in investing activities in the nine months ended March 31, 2026 was $2,785,375, compared to zero in the nine months ended
March 31, 2025. Such fluctuation was due to our initial capital expenditures on a jointly owned utility-scale battery manufacturing facility
currently under construction in the State of Georgia (see “Other Developments” below) as well as the cash portion of our purchase
price of an acquisition of intangible and tangible assets from Neubau Energy Inc., which closed
in October 2025.
21
Financing activities.
Net cash provided by financing activities in the nine months ended March 31, 2026 was $21,628,221 compared to $3,051,054 in the nine months
ended March 31, 2025. In the nine months ended March 31, 2026, we completed the following equity financings: (i) in November 2025, we
entered into a private equity offering with accredited investors group under which we issued a total of 5,200,000 shares of our common
stock at an offering price of $2.50 per share for gross proceeds of $13,000,000, which closed in two tranches in December 2025 and February
2026; and (ii) in January 2026, we closed a registered direct offering of a total of 2,100,841 shares of our common stock at an offering
price of $4.76 per share resulting in net proceeds of $9,301,844. Beginning in November 2024, we also made short-term borrowings from
two private lenders, primarily to finance inventory purchases. In the nine months ended March 31, 2026, we made borrowings from these
lenders in the total amount of $6,936,891 and repayments in the amount of $ 7,610,514.
In the nine months ended March
31, 2025, we made borrowings from our two private lenders in the total amount of $2,581,845 and repayments in the amount of $778,191.
In February 2025, we closed a private equity offering with accredited investors under which we issued a total of 543,500 shares of our
common stock to the investors at an offering price of $2.00 per share resulting in gross proceeds of $1,087,000. In December 2024, we
also received proceeds from the exercise of warrants issued in our August 2022 public offering in the amount of $160,400.
As of March 31, 2026, we had
a consolidated cash balance of approximately $11.5 million and consolidated net working capital of approximately $19.5 million, an increase
of approximately $15.4 million in the recent quarter. Currently, we are not generating a break-even level of net operating cash flow from
our net sales. However, we anticipate that demand for our products will ultimately increase over time and that, with our current credit
sources and the proceeds of our three equity financings in the nine months ended March 31, 2026, we will have sufficient cash to operate
for at least the next 12 months (see “Other Developments ” below).
Other Developments
In January 2026, we executed
a series of joint venture agreements with the U.S. affiliate of a foreign entity for the formation of a new domestic limited liability
company to jointly own and operate a planned utility-scale battery manufacturing facility in the State of Georgia. Pursuant to these agreements,
the Company has an 80% ownership interest in the joint venture company, and the U.S. affiliate of the foreign entity has a 20% ownership
interest.
In accordance with the joint
venture agreements, we made our initial capital contribution of $7,000,000 in January 2026 and expect to make an additional capital contribution
of $8,000,000 in June 2026, which is primarily to fund the purchase of equipment. Further, we are expected to make additional capital
contributions to the joint venture company through June 30, 2027 in total amounts of up to $25,000,000, pursuant to the joint venture
agreements. We presently anticipate funding those additional capital contributions from the proceeds of one or more equity and/or debt
financings, subject to market conditions. However, there can be no assurance that we will be successful in raising sufficient proceeds
from such private offerings in order to fully satisfy our obligations for the additional capital contributions to the joint venture company.
To the extent that we may be unable to raise sufficient proceeds in order to fully satisfy our obligations for the additional capital
contributions to the joint venture company, the parent company of the same foreign entity will be permitted to bring in one or more new
members of the joint venture company to fund such additional capital contributions which would dilute our present 80% majority ownership
of the joint venture company.
We continue to monitor current
international developments occurring in Iran and Ukraine. However, we do not believe that they will have a significant impact on either
the domestic markets for our products or the international supply chains for our product components, which are largely sourced from Asia.
Presently, our two main raw
material components, batteries and inverters, are imported from different suppliers in China and, until recently, were subject to fairly
low tariff rates that had been in effect for several years. Beginning in April 2025, the Trump Administration implemented a significant
increase in tariff rates based on the authority of the International Emergency Economic Powers Act (“IEEPA”) on all goods
imported from China, although it was temporarily suspended for 90 days in April 2025 and the tariff rate was lowered in November 2025,
subject to judicial review. In February 2026, the Supreme Court declared the tariffs to be unconstitutional based on the authority of
IEEPA, therefore, the Administration is considering alternative approaches to implementing tariffs that it believes would be sustained
in a judicial review. Prior to the tariff escalation in April 2025, we had anticipated the likelihood of facing such a tariff increase
and began stockpiling our inventory of these two components in order to reduce the impact of the tariffs.
22
Off-Balance Sheet Arrangements
We have no obligations, assets
or liabilities which would be considered off-balance sheet arrangements as defined in Item 303 of Regulation S-K.
Critical Accounting Policies and Estimates
Our discussion and analysis
of our financial condition and results of operations are based on consolidated financial statements which have been prepared in accordance
with generally accepted accounting principles in the United States. The preparation of these consolidated financial statements requires
us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We believe that certain
accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.
See “Note 1. Business and Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements set
forth above and under “Item 8. Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year
ended June 30, 2025, as filed with the SEC on September 29, 2025, for a further description of our critical accounting policies and estimates.
None of those policies are deemed to be critical accounting policies nor critical accounting estimates.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Information for this Item
is not required as the Registrant is a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We have established and maintain
a system of disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed
in our reports filed with the Securities and Exchange Commission pursuant to the Exchange Act, is recorded, processed, summarized and
reported within the time periods specified in the rules and forms of the Commission and that such information is accumulated and communicated
to our management, including our Chief Executive Officer, who is our principal executive officer, and Chief Financial Officer, who is
our principal financial and accounting officer, to allow timely decisions regarding required disclosures.
As of March 31, 2026, our
Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the design and operation of our disclosure controls
and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based on that evaluation, our Chief Executive Officer
and Chief Financial Officer have concluded that, as a result of the material weakness relating to the lack of segregation of duties, our
disclosure controls and procedures as of the end of the period covered by this Quarterly Report were not effective. Due to our size and
nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. We will be required to
hire additional personnel in order to remediate our material weakness.
Limitations on Effectiveness of Controls and
Procedures
In designing and evaluating
the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated,
can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and
procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating
the benefits of possible controls and procedures relative to their costs.
Changes in Internal Controls over Financial
Reporting
There was no change in our
internal controls over financial reporting that occurred during the quarter ended March 31, 2026, that has materially affected, or is
reasonably likely to materially affect, our internal controls over financial reporting.
23
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Although we may, from time
to time, be involved in litigation and claims arising out of our operations in the normal course of business, we are not currently a party
to any material legal proceeding. In addition, we are not aware of any material legal or governmental proceedings against us, or contemplated
to be brought against us.
ITEM 1A. RISK FACTORS
There have been no material
changes from the risk factors previously disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended
June 30, 2025, as filed with the SEC on September 29, 2025 (the “Form 10-K”), under the heading “Risk
Factors”, and investors should review the risks provided in the Form 10-K prior to making an investment in the Company. The
business, financial condition and operating results of the Company can be affected by a number of factors, whether currently known or
unknown, including but not limited to those described in the Form 10-K for the year ended June 30, 2025, under “Risk
Factors”, any one or more of which could, directly or indirectly, cause the Company’s actual financial condition and operating
results to vary materially from past, or from anticipated future, financial condition and operating results. Any of these factors, in
whole or in part, could materially and adversely affect the Company’s business, financial condition, operating results and stock
price.
ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Except as set forth in a previously
filed Form 8-K, in the three months ended March 31, 2026, and in the subsequent period through the date hereof, we had the following unregistered
issuance of our common stock, which was made pursuant to exemptions from registration as set forth in Section 4(a)(2) and/or Section 3(a)(9)
of the Securities Act, as applicable to each issuance: On February 9, 2026, we closed the second tranche of a private equity offering
entered into in November 2025 with an institutional investor under which we issued a total of 4,000,000 shares of our common stock to
the investor at an offering price of $2.50 per share resulting in gross proceeds to the Company in the amount of $10,000,000. We expect
to use the proceeds of this private offering to meet working capital needs and for other general corporate purposes.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
24
ITEM 5. OTHER INFORMATION
During the period covered by
this Quarterly Report, none of the Company’s directors or executive officers has adopted or terminated a Rule 10b5-1 trading arrangement
or a non-Rule 10b5-1 trading arrangement (each as defined in Item 408 of Regulation S-K under the Securities Exchange Act of 1934, as
amended).
On May 12,
2026, the Company entered into a Consulting Services Agreement (the “Consulting Agreement”) with Infinite Grid Capital, LP,
a Delaware limited partnership (“IGC”), pursuant to which the Company engaged IGC to provide offtake origination and related
advisory services in connection with the Company’s battery energy storage manufacturing operations being undertaken through NeoVolta
Power, LLC, a Delaware limited liability company (the “Joint Venture”).
Under the
Consulting Agreement, IGC has provided, and will continue to provide, strategic advisory services to the Company, including services previously
rendered in connection with the formation and development of the Joint Venture (the “Pre-Signing Services”) and ongoing offtake
origination services (the “Offtake Services”). The Offtake Services include identifying and evaluating potential offtake counterparties,
advising on the structuring of offtake arrangements and assisting in the negotiation of term sheets, letters of intent and definitive
offtake agreements.
As consideration
for the Pre-Signing Services, the Offtake Services and the entry into the Consulting Agreement, the Company will issue IGC 500,000 shares
of the Company’s common stock (the “Signing Fee”). In addition, IGC is entitled to receive a success fee (the “Offtake
Fee”) for each qualifying offtake agreement attributable to IGC’s direct and material causal contribution, calculated as a
percentage of gross revenue received by the Company for energy storage equipment and associated hardware under the applicable offtake
agreement (“Project Equipment Revenue”), as follows: (i) 5.0% for projects with contracted capacity of less than 100 MWh;
(ii) 4.0% for projects with contracted capacity of 100 MWh or greater but less than 250 MWh; and (iii) 3.0% for projects with contracted
capacity of 250 MWh or greater. The maximum Offtake Fee payable with respect to any single offtake agreement is $3,000,000, and multiple
offtake agreements with the same counterparty or as part of a single project are aggregated for purposes of determining applicable capacity
thresholds and fee percentages. Each Offtake Fee is payable, at the mutual election of the Company and IGC, in cash, shares of Company
common stock (or prefunded warrants), or a combination thereof. If payable in shares, the number of shares is determined by dividing the
applicable Offtake Fee by the “Minimum Price” calculated in accordance with Nasdaq Listing Rule 5635(d) as of the applicable
determination date. To the extent that any issuance of common stock would cause IGC to beneficially own in excess of 4.9% of the outstanding
shares of common stock, such excess shares will instead be issued in the form of prefunded warrants, each with an exercise price of $0.001
per share, exercisable immediately upon issuance and containing a 9.9% beneficial ownership limitation. The shares of common stock are
being and will be issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as
amended.
The Consulting
Agreement provides IGC with piggyback registration rights with respect to all shares of common stock and other equity securities held
by IGC or its affiliates that are not then registered for resale. In addition, the Company is required to file a registration statement
covering the resale of the Signing Fee shares and cause such registration statement to be declared effective by no later than June 30,
2026.
The Consulting
Agreement continues until completion of the services, unless earlier terminated by either party upon 45 days’ prior written notice
or for material breach (subject to a 30-day cure period). Following termination or expiration, IGC is entitled to an Offtake Fee with
respect to offtake agreements executed within 90 days with counterparties first introduced by IGC during the term and identified on a
written list delivered by IGC prior to the effective date of termination.
On May 12, 2026, the Company also entered into a Letter Agreement
(the “Letter Agreement”) with IGC, pursuant to which the Company granted IGC certain preemptive rights, registration rights,
and board observation rights. During the period ending December 31, 2027, IGC has a preemptive right to participate in any financing
by the Company, the proceeds of which are intended to fund any capital contribution to the Joint Venture, on the same terms and conditions
as such financing is offered to other investors. The preemptive rights do not apply to the Company’s use of its at-the-market facility
to raise capital for ongoing corporate obligations (excluding Joint Venture-related obligations) in an amount not to exceed $1,000,000
per quarter, or to financings for acquisitions or strategic transactions unrelated to the Joint Venture. The Company is required to file
a registration statement covering the resale of the common stock acquired by IGC in the Company’s private placement that was completed
in February 2026, and to cause such registration statement to be declared effective by no later than June 30, 2026. IGC has the right,
upon written notice to the Company, to designate a representative to attend all board and committee meetings as a non-voting observer,
with the same notice of meetings and access to materials provided to directors. The Letter Agreement terminates at such time as IGC holds
fewer than 250,000 shares purchased pursuant to the private placement that was completed in February 2026.
25
ITEM 6. EXHIBITS
Exhibit No.
Exhibit Description
3.1
Amended and Restated Articles of Incorporation of NeoVolta, Inc. (incorporated by reference to exhibit 2.1 of the Company’s Form 1-A (file no. 024-10942)).
3.2
Second Amended and Restated Bylaws of NeoVolta, Inc. (incorporated by reference to exhibit 3.3 of the Company’s Form S-1 (file no. 333-264275)).
10.1
Operating Agreement among NeoVolta Power, LLC and the Members dated January 13, 2026 (incorporated by reference to exhibit 10.1 of the Company’s Form 8-K filed January 20, 2026)
10.2
Contribution Agreement among NeoVolta Power, LLC and the Members dated January 13, 2026 (incorporated by reference to exhibit 10.2 of the Company’s Form 8-K filed January 20, 2026)
10.3
Form of Securities Purchase Agreement, by and among NeoVolta Inc. and the Purchasers, dated January 22, 2026 (incorporated by reference to exhibit 10.1 of the Company’s Form 8-K filed January 23, 2026)
10.4*
Technical Services Agreement between NeoVolta Power, LLC and Can Current Corporation, dated March 20, 2026
10.5
Form of Subscription Agreement in $2.50 private offering (incorporated by reference to exhibit 10.3 of the Company’s Form 10-Q filed February 13, 2026)
10.6
Form of RSU Cancellation Agreement, by and among NeoVolta, Inc. and each of Ardes Johnson and Steve Bond, dated February 23, 2026 (incorporated by reference to exhibit 10.1 of the Company’s Form 8-K filed February 25, 2026)
10.7
Sales Agreement, dated March 27, 2026, by and between NeoVolta, Inc. and Needham & Company, LLC (incorporated by reference to exhibit 1.1 of the Company’s Form 8-K filed March 27, 2026)
10.8
First Amendment to Employment Agreement dated March 26, 2026 between NeoVolta, Inc. and Steve Bond (incorporated by reference to exhibit 10.1 of the Company’s Form 8-K filed March 27, 2026)
10.9
Amended and Restated Operating Agreement of NeoVolta Power, LLC, dated April 15, 2026 (incorporated by reference to exhibit 10.1 of the Company’s Form 8-K filed April 21, 2026)
10.10
First Amendment to Contribution Agreement, dated April 15, 2026 (incorporated by reference to exhibit 10.2 of the Company’s Form 8-K filed April 21, 2026)
10.11
Asset Purchase Agreement between Can Current Corporation and NeoVolta Power, LLC, dated April 15, 2026 (incorporated by reference to exhibit 10.3 of the Company’s Form 8-K filed April 21, 2026)
10.12
Management Services Agreement between NeoVolta Inc. and Potisedge Technology Pte Ltd., dated April 20, 2026 (incorporated by reference to exhibit 10.4 of the Company’s Form 8-K filed April 21, 2026)
10.13*
Severance Agreement and General Release by and between NeoVolta, Inc. and Michael Mendik
10.14*
Consulting Services Agreement dated May 12, 2026 by and between NeoVolta, Inc. and Infinite Grid Capital, LP.
10.15*
Side Letter Agreement dated May 12, 2026 by and between NeoVolta, Inc. and Infinite Grid Capital, LP.
31.1*
Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes- Oxley Act of 2002
31.2*
Certification of Principal Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
32.1*
Certification of Principal Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*
Certification of Principal Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS *
Inline XBRL Instance Document
101.SCH *
Inline XBRL Taxonomy Extension Schema Document
101.CAL *
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF *
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB *
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE *
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
______________________
* Filed herewith.
+ Pursuant
to Item 601(b)(10)(iv) of Regulation S-K promulgated by the SEC, certain portions of this exhibit have been redacted. The Company hereby
agrees to furnish supplementally to the SEC, upon its request, an unredacted copy of this exhibit.
26
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
NEOVOLTA, INC.
May 14, 2026
/s/ H. Ardes Johnson
H. Ardes Johnson
Chief Executive Officer
(Principal Executive Officer)
May 14, 2026
/s/ Steve Bond
Steve Bond
Chief Financial Officer
(Principal Financial/Accounting
Officer)
27
/stocks — the workspaceLOADING